• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度高血压治疗环节:来自国家非传染性疾病监测调查的结果。

Hypertension treatment cascade in India: results from National Noncommunicable Disease Monitoring Survey.

机构信息

Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.

Indian Council Medical Research (ICMR)-National Centre for Disease Informatics and Research (NCDIR), Bengaluru, Karnataka, India.

出版信息

J Hum Hypertens. 2023 May;37(5):394-404. doi: 10.1038/s41371-022-00692-y. Epub 2022 May 5.

DOI:10.1038/s41371-022-00692-y
PMID:35513442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10156594/
Abstract

Hypertension is a major risk factor for ischemic heart disease and stroke. We estimated prevalence, awareness, treatment, and control of hypertension along with its determinants in India. We used data from the National NCD Monitoring Survey-(NNMS-2017-2018) which studied one adult (18-69 years) from a representative sample of households across India and collected information on socio-demographic variables, risk factors for NCDs and treatment practices. Blood pressure was recorded digitally and hypertension was defined as systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg or currently on medications. Awareness was defined as being previously diagnosed with hypertension by a health professional; on treatment as taking a dose of medication once in the last 14 days and; control as SBP < 140 mmHg and DBP < 90 mmHg. Multivariate Logistic regression was performed to estimate determinants. Out of 10,593 adults with a blood pressure measurement (99.4%), 3017 (28.5%; 95% CI: 27.0-30.1) were found to have hypertension. Of these hypertensives, 840 (27.9%; 95% CI: 25.5-30.3) were aware, 438 (14.5%; 95% CI: 12.7-16.5) were under treatment and, 379 (12.6%; 95% CI: 11.0-14.3) were controlled. Significant determinants of awareness were being in the age group 50-69 years (aOR 2.45 95% CI: 1.63-3.69), women (1.63; 95% CI: 1.20-2.22) and from higher wealth quintiles. Those in the age group 50-69 (aOR 4.80; 95% CI: 1.74-13.27) were more likely to be under treatment. Hypertension control was poorer among urban participants (aOR 0.55; 95% CI: 0.33-0.90). Significant regional differences were noted, though without any clear trend. One-fifth of the patients were being managed at public facilities. The poor population-level hypertension control needs strengthening of hypertension services in the Universal Health Coverage package.

摘要

高血压是缺血性心脏病和中风的主要危险因素。我们估计了印度高血压的患病率、知晓率、治疗率和控制率及其决定因素。我们使用了国家非传染性疾病监测调查(NNMS-2017-2018)的数据,该调查研究了印度代表性家庭样本中的一名成年人(18-69 岁),收集了社会人口统计学变量、非传染性疾病风险因素和治疗实践方面的信息。血压是通过数字记录的,高血压定义为收缩压(SBP)≥140mmHg 或舒张压(DBP)≥90mmHg 或正在服用药物。知晓率定义为曾被卫生专业人员诊断患有高血压;治疗率定义为在过去 14 天内服用过一次药物;控制率定义为 SBP<140mmHg 和 DBP<90mmHg。我们进行了多变量逻辑回归分析以估计决定因素。在有血压测量的 10593 名成年人中(99.4%),有 3017 人(28.5%;95%CI:27.0-30.1)患有高血压。在这些高血压患者中,有 840 人(27.9%;95%CI:25.5-30.3)知晓自己的病情,有 438 人(14.5%;95%CI:12.7-16.5)正在接受治疗,有 379 人(12.6%;95%CI:11.0-14.3)得到了控制。知晓率的显著决定因素是年龄在 50-69 岁之间(调整后的比值比[aOR]为 2.45;95%CI:1.63-3.69)、女性(1.63;95%CI:1.20-2.22)和来自更高的财富五分位数。50-69 岁年龄组(aOR 为 4.80;95%CI:1.74-13.27)更有可能接受治疗。城市参与者的高血压控制较差(aOR 为 0.55;95%CI:0.33-0.90)。虽然没有明显的趋势,但我们注意到了显著的区域差异。五分之一的患者在公共设施接受管理。在全民健康覆盖方案中,需要加强高血压服务,以改善这一人群的高血压整体控制水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a4/10156594/a9b319655fff/41371_2022_692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a4/10156594/a9b319655fff/41371_2022_692_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a4/10156594/a9b319655fff/41371_2022_692_Fig1_HTML.jpg

相似文献

1
Hypertension treatment cascade in India: results from National Noncommunicable Disease Monitoring Survey.印度高血压治疗环节:来自国家非传染性疾病监测调查的结果。
J Hum Hypertens. 2023 May;37(5):394-404. doi: 10.1038/s41371-022-00692-y. Epub 2022 May 5.
2
Regional estimates of noncommunicable diseases associated risk factors among adults in India: results from National Noncommunicable Disease Monitoring Survey.印度成年人与非传染性疾病相关的风险因素的区域估计:国家非传染性疾病监测调查结果。
BMC Public Health. 2022 May 30;22(1):1069. doi: 10.1186/s12889-022-13466-5.
3
Prevalence and Factors Associated with Hypertension among Community-Dwelling Adolescents in a Rural Area of Haryana, India, Using AAP 2017 and NHBPEP Criteria.使用 AAP 2017 和 NHBPEP 标准评估印度哈里亚纳邦农村地区社区青少年高血压的患病率及相关因素。
Indian J Pediatr. 2022 Nov;89(11):1099-1106. doi: 10.1007/s12098-022-04256-3. Epub 2022 Jul 13.
4
National noncommunicable disease monitoring survey (NNMS) in India: Estimating risk factor prevalence in adult population.印度全国非传染性疾病监测调查(NNMS):估算成年人口中的风险因素患病率。
PLoS One. 2021 Mar 2;16(3):e0246712. doi: 10.1371/journal.pone.0246712. eCollection 2021.
5
Inequalities and risk factors analysis in prevalence and management of hypertension in India and Nepal: a national and subnational study.印度和尼泊尔高血压患病率及管理中的不平等与风险因素分析:一项全国及次国家级研究
BMC Public Health. 2020 Sep 3;20(1):1341. doi: 10.1186/s12889-020-09450-6.
6
Prevalence, Awareness, Treatment and Control of Diabetes in India From the Countrywide National NCD Monitoring Survey.来自全国非传染性疾病监测调查的印度糖尿病患病率、知晓率、治疗率及控制率
Front Public Health. 2022 Mar 14;10:748157. doi: 10.3389/fpubh.2022.748157. eCollection 2022.
7
Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran.伊朗成年人高血压前期和高血压的知晓、治疗与控制情况
Arch Iran Med. 2016 Jul;19(7):456-64.
8
Prevalence and determinants of hypertension in the urban and rural population of a north Indian district.印度北部某地区城乡人口中高血压的患病率及其决定因素
East Afr J Public Health. 2009 Dec;6(3):268-73.
9
Control of hypertension among teachers in schools in Kerala (CHATS-K), India.印度喀拉拉邦学校教师高血压控制研究(CHATS-K)。
Indian Heart J. 2020 Sep-Oct;72(5):416-420. doi: 10.1016/j.ihj.2020.06.005. Epub 2020 Jun 27.
10
Blood pressure and noncommunicable diseases in middle-aged and older adults in China.中国中老年人群的血压与非传染性疾病
PLoS One. 2018 Nov 2;13(11):e0206635. doi: 10.1371/journal.pone.0206635. eCollection 2018.

引用本文的文献

1
Spatial analysis of hypertension's awareness, treatment and control in India: evidence from national family health survey 2019-21.印度高血压知晓率、治疗率和控制率的空间分析:来自2019 - 2021年全国家庭健康调查的证据
BMC Public Health. 2025 Aug 22;25(1):2882. doi: 10.1186/s12889-025-23590-7.
2
Serum fibrinogen & total cholesterol: A significant primary biomarker and its interrelationship in stroke.血清纤维蛋白原与总胆固醇:一种重要的主要生物标志物及其在中风中的相互关系。
Caspian J Intern Med. 2025 Jun 23;16(3):525-535. doi: 10.22088/cjim.16.3.525. eCollection 2025 Summer.
3
Socioeconomic and sex disparities in hypertension and diabetes mellitus care cascade among tribal populations in Odisha, India: findings from the Odisha Tribal Family Health Survey (OTFHS), 2022-23.

本文引用的文献

1
Hypertension awareness, treatment, and control and their association with healthcare access in the middle-aged and older Indian population: A nationwide cohort study.中年和老年印度人群的高血压知晓率、治疗率和控制率及其与医疗保健可及性的关系:一项全国性队列研究。
PLoS Med. 2022 Jan 4;19(1):e1003855. doi: 10.1371/journal.pmed.1003855. eCollection 2022 Jan.
2
The burden of hypertension and unmet need for hypertension care among men aged 15-54 years: a population-based cross-sectional study in India.15至54岁男性高血压负担及高血压护理未满足需求:印度一项基于人群的横断面研究
J Biosoc Sci. 2022 Nov;54(6):1078-1099. doi: 10.1017/S0021932021000481. Epub 2021 Oct 4.
3
印度奥里萨邦部落人群高血压和糖尿病护理流程中的社会经济与性别差异:2022 - 2023年奥里萨邦部落家庭健康调查(OTFHS)的结果
BMC Public Health. 2025 Jul 16;25(1):2477. doi: 10.1186/s12889-025-23587-2.
4
Prevalence of Hypertension and Its Associated Factors Among Adult People Living with HIV/AIDS at Anti-Retroviral Treatment (ART) Centers in Mumbai, India.印度孟买抗逆转录病毒治疗(ART)中心成年艾滋病毒/艾滋病感染者中高血压及其相关因素的患病率
HIV AIDS (Auckl). 2025 Jun 3;17:105-119. doi: 10.2147/HIV.S499508. eCollection 2025.
5
Association Between Abdominal Obesity, Body Mass Index, and Hypertension in India: Evidence From a Large Nationally Representative Data.印度腹部肥胖、体重指数与高血压之间的关联:来自大型全国代表性数据的证据
J Clin Hypertens (Greenwich). 2025 Mar;27(3):e70034. doi: 10.1111/jch.70034.
6
Exploring the future of nutrigenomics: dietitians' perceptions on integration in Indian practice.探索营养基因组学的未来:营养师对其在印度实践中整合的看法。
Genes Nutr. 2025 Mar 17;20(1):7. doi: 10.1186/s12263-024-00760-7.
7
Investigating the enablers and barriers for hypertension control in Dakar: a qualitative system effectiveness study.探究达喀尔高血压控制的促进因素和障碍:一项定性系统有效性研究。
BMJ Open. 2025 Mar 3;15(3):e089548. doi: 10.1136/bmjopen-2024-089548.
8
Effects of medication procurement reforms and extended prescription duration on medication coverage for hypertension in India's public health system: a modelling study.药物采购改革和延长处方期限对印度公共卫生系统中高血压药物覆盖范围的影响:一项建模研究。
BMJ Public Health. 2025 Jan 25;3(1):e001044. doi: 10.1136/bmjph-2024-001044. eCollection 2025 Jan.
9
Prediction of primary Hypertension in Primary Health Care Settings in Coastal Karnataka Using Artificial Neural Network.使用人工神经网络预测卡纳塔克邦沿海地区初级卫生保健机构中的原发性高血压
Curr Hypertens Rev. 2025;21(2):82-93. doi: 10.2174/0115734021329874250222053144.
10
Standardisation of Blood Pressure Measurement Among Patients Attending an Urban Primary Health Centre: A Quality Improvement Initiative.城市基层医疗中心就诊患者血压测量的标准化:一项质量改进举措。
Cureus. 2024 Nov 16;16(11):e73811. doi: 10.7759/cureus.73811. eCollection 2024 Nov.
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.
全球高血压患病率趋势及 1990 至 2019 年治疗和控制进展情况:1040 万参与者、1201 项人群代表性研究的汇总分析
Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.
4
Awareness, treatment, and control of hypertension in adults aged 45 years and over and their spouses in India: A nationally representative cross-sectional study.印度 45 岁及以上成年人及其配偶的高血压知晓率、治疗率和控制率:一项全国代表性横断面研究。
PLoS Med. 2021 Aug 24;18(8):e1003740. doi: 10.1371/journal.pmed.1003740. eCollection 2021 Aug.
5
Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS).印度基层卫生机构应对主要非传染性疾病的准备情况:国家非传染性疾病监测调查(NNMS)的结果。
BMC Health Serv Res. 2021 Jul 31;21(1):757. doi: 10.1186/s12913-021-06530-0.
6
National noncommunicable disease monitoring survey (NNMS) in India: Estimating risk factor prevalence in adult population.印度全国非传染性疾病监测调查(NNMS):估算成年人口中的风险因素患病率。
PLoS One. 2021 Mar 2;16(3):e0246712. doi: 10.1371/journal.pone.0246712. eCollection 2021.
7
India Hypertension Control Initiative-Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics.印度高血压控制倡议-24 个哨点诊所队列中的高血压治疗和血压控制。
J Clin Hypertens (Greenwich). 2021 Apr;23(4):720-729. doi: 10.1111/jch.14141. Epub 2020 Dec 23.
8
A perspective of private health care providers in the state of Madhya Pradesh on adopting key strategies of the India hypertension control initiative.中央邦私营医疗保健提供者对采用印度高血压控制倡议关键策略的看法。
J Clin Hypertens (Greenwich). 2020 Aug;22(8):1321-1327. doi: 10.1111/jch.13944. Epub 2020 Jul 20.
9
Scaling up effective treatment of hypertension-A pathfinder for universal health coverage.扩大高血压有效治疗规模——全民健康覆盖的探路者。
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1442-1449. doi: 10.1111/jch.13655. Epub 2019 Sep 23.
10
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.44 个低收入和中等收入国家的高血压护理状况:来自 110 万成年人的全国代表性个体水平数据的横断面研究。
Lancet. 2019 Aug 24;394(10199):652-662. doi: 10.1016/S0140-6736(19)30955-9. Epub 2019 Jul 18.